Fundació Puigvert Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2008
NCT01217125
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Fundacio Puigvert | Fundacio Puigvert, Barcelona | Programa de Reproducción Asistida F. Puigvert - HSCSP

Active Ingredients

Drugs in Phase 4 Trials (3)

follitropin alfa (1 trial)

menopausal gonadotropin (1 trial)

sirolimus (rapamune) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angiomyolipoma (Phase 4)

Polycystic Ovary Syndrome (Phase 4)

Tuberous Sclerosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3